series-b
Stage
1
Investors
About
Synergia Medical develops an investigational optoelectronic neuromodulation implant (NAO.VNS) for vagus nerve stimulation that is designed to be MRI-compatible and immune to electromagnetic interference. The company has reported first-in-human implantations in Belgium as part of its AURORA clinical study.
Explore Synergia Medical's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.